Antonio Giordano
Antonio Giordano
Commendatore OMRI BAR
Antonio Giordano[edit | edit source]
Antonio Giordano is an Italian-American pathologist and geneticist known for his contributions to cancer research and molecular biology. He is the founder and director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, Pennsylvania.
Early Life and Education[edit | edit source]
Antonio Giordano was born in Naples, Italy. He pursued his medical degree at the University of Naples Federico II, where he developed an interest in the field of oncology. Giordano later moved to the United States to further his studies and research in cancer biology.
Career[edit | edit source]
Giordano's career in the United States began with his work at the Cold Spring Harbor Laboratory, where he collaborated with renowned scientists in the field of genetics. He later joined the faculty at Thomas Jefferson University in Philadelphia, where he continued his research on the molecular mechanisms of cancer.
In 1993, Giordano founded the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. The institute focuses on understanding the genetic and molecular basis of cancer and developing new therapeutic strategies.
Research Contributions[edit | edit source]
Antonio Giordano is recognized for his discovery of several tumor suppressor genes, including RB2/p130, which plays a critical role in cell cycle regulation and tumor suppression. His research has significantly advanced the understanding of the genetic alterations involved in cancer development.
Giordano's work has also explored the role of microRNAs in cancer and the potential of targeting these small non-coding RNAs for cancer therapy. His studies have contributed to the development of novel diagnostic and therapeutic approaches in oncology.
Awards and Honors[edit | edit source]
Throughout his career, Antonio Giordano has received numerous awards and honors for his contributions to cancer research. He has been recognized by various scientific organizations and has served on the editorial boards of several prestigious scientific journals.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
